Budesonide 0.025% Topical Ointment is a semi-solid formulation dispensed in a tube, designed for external application to the skin. It features a greasy or oily base that enhances the delivery of the medication for localized treatment. This ointment is primarily used to treat skin conditions such as inflammation, infections, and to aid in wound healing.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Budesonide 0.025% Topical Ointment is a compounded semi-solid formulation designed for external application to the skin. This ointment is dispensed in a tube and utilizes a greasy or oily base, which enhances the delivery of the medication to the affected area. The ointment's base not only aids in medication absorption but also provides moisturizing properties beneficial for various skin conditions.
Budesonide is a potent corticosteroid with strong anti-inflammatory and immunosuppressive properties. When applied topically, it works by reducing inflammation, itching, and redness associated with a range of dermatological conditions. It inhibits the release of inflammatory substances in the body, thereby alleviating symptoms and promoting healing of the skin.
By targeting localized inflammation, Budesonide 0.025% Topical Ointment helps to relieve discomfort and improve the appearance of the skin affected by these conditions.
For patients, it is important to apply the ointment exactly as prescribed by a healthcare professional. Typically, a thin layer should be gently massaged into the affected skin areas once or twice daily, depending on the severity of the condition and the doctor's instructions. Care should be taken to avoid contact with the eyes, mouth, and other sensitive areas. The treatment duration may vary based on individual response and should be regularly reviewed by the prescribing physician.
Prescribers should consider this compounded ointment when standard therapies are ineffective or unsuitable for the patient. The concentration of Budesonide can be customized to meet specific patient needs, providing a tailored approach to treatment. The ointment base can also be selected to enhance patient compliance and comfort, especially for those with dry or sensitive skin.
Patients should inform their healthcare provider of any existing medical conditions, allergies, or other medications they are taking to prevent potential interactions or side effects. Use of topical corticosteroids like Budesonide may carry a risk of skin thinning, stretch marks, or hormonal effects if used excessively or over large body areas. Close monitoring by a healthcare professional is recommended to minimize these risks.
Possible side effects include mild skin irritation, dryness, or redness at the application site. If these symptoms persist or worsen, or if signs of skin infection occur, patients should contact their healthcare provider promptly. It is also advised to avoid prolonged use of the ointment unless directed by a physician, to prevent potential adverse effects.
This compounded Budesonide ointment offers a personalized treatment option that can be adjusted according to patient requirements, ensuring optimal therapeutic outcomes.
If you have any questions or need further information about Budesonide 0.025% Topical Ointment, please do not hesitate to reach out to us.
Budesonide 0.025% topical ointment is a corticosteroid formulation used for its anti-inflammatory properties, primarily in the treatment of skin conditions such as eczema, psoriasis, and dermatitis. While topical application generally limits systemic absorption, it is important to consider potential drug interactions, especially in patients with extensive skin involvement or those using other medications concurrently.
For patients and prescribers, it is crucial to be aware that the use of budesonide, even topically, may interact with other medications that affect the cytochrome P450 3A4 (CYP3A4) enzyme system. Budesonide is metabolized by CYP3A4, and concurrent use of strong inhibitors of this enzyme, such as ketoconazole, itraconazole, or ritonavir, may increase systemic exposure to budesonide, potentially enhancing its effects and side effects. This could lead to increased risk of systemic corticosteroid effects, such as adrenal suppression, especially if large areas of skin are treated or if occlusive dressings are used.
Patients using other topical or systemic corticosteroids should be monitored for cumulative effects, as this may increase the risk of side effects such as skin thinning, easy bruising, or hormonal imbalances. Additionally, caution is advised when using budesonide ointment in conjunction with other immunosuppressive therapies, as this may further suppress the immune response, increasing the risk of infections.
It is also important to consider potential interactions with other topical agents. For instance, applying other topical medications or cosmetics on the same area may alter the absorption and efficacy of budesonide. Patients should be advised to apply budesonide ointment first and allow it to absorb before applying other products.
Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs and supplements, to assess for potential interactions. Prescribers should evaluate the patient's medication regimen and consider the risk-benefit ratio of using budesonide ointment, especially in patients with complex medication profiles or those with a history of drug interactions.
If you have any questions or need further information regarding the use of budesonide 0.025% topical ointment and its potential interactions, please reach out to us at Bayview Pharmacy. We are here to assist both patients and healthcare providers in ensuring safe and appropriate use of this medication.
Budesonide 0.025% Topical Ointment is a semi-solid formulation specifically designed for external application to the skin. This ointment is dispensed in a tube, making it convenient for precise application to affected areas. The formulation is characterized by its greasy or oily base, which plays a crucial role in the delivery of the active medication, budesonide, to the skin. The ointment's base not only facilitates the penetration of budesonide into the skin but also provides a protective barrier that helps retain moisture, which is beneficial for skin healing and repair.
Budesonide is a potent corticosteroid that works by reducing inflammation and suppressing the immune response in the skin. When applied topically, budesonide interacts with specific receptors in the skin cells, leading to a decrease in the production of inflammatory mediators. This action helps alleviate symptoms associated with skin conditions such as inflammation, redness, and itching. By controlling these symptoms, budesonide aids in the healing process of the skin and improves the overall condition of the affected area.
The formulation is particularly useful for localized treatment of skin conditions, allowing for targeted therapy that directly addresses the affected area without significant systemic absorption. This makes it an ideal choice for managing conditions such as eczema, psoriasis, and other inflammatory skin disorders where localized treatment is preferred.
For prescribers, it is important to consider the specific needs of the patient when recommending Budesonide 0.025% Topical Ointment. The formulation's greasy base may not be suitable for all patients, particularly those who prefer a less oily feel on their skin. However, the benefits of enhanced medication delivery and moisture retention often outweigh these considerations, especially in cases where skin barrier repair is a priority.
Patients using this ointment should apply it as directed by their healthcare provider, typically in a thin layer to the affected area. It is important to follow the prescribed regimen to achieve optimal results and to avoid potential side effects associated with overuse. Patients should also be aware of any signs of adverse reactions and report them to their healthcare provider promptly.
If you have any questions about Budesonide 0.025% Topical Ointment or its use, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to ensure appropriate treatment.
Budesonide 0.025% Topical Ointment is used for the treatment of skin conditions such as inflammation, infections, or to aid in wound healing. It is designed for external application to the skin.
Apply a thin layer of the ointment to the affected area of the skin as directed by your healthcare provider. Make sure to wash your hands before and after application unless the treatment is for your hands.
Consult your healthcare provider before applying the ointment to open wounds. It is typically used for localized treatment of skin conditions, but your provider will give specific instructions based on your condition.
Some possible side effects include skin irritation, dryness, or redness at the application site. If you experience severe side effects or signs of an allergic reaction, contact your healthcare provider immediately.
The frequency of application will depend on your specific condition and the instructions provided by your healthcare provider. Follow their guidance carefully for optimal results.
Consult your healthcare provider before using the ointment on your face, as the skin on the face can be more sensitive. They will provide guidance based on your specific condition.
Use in children should be under the guidance of a healthcare provider. They will determine if it is appropriate based on the child's condition and age.
Discuss with your healthcare provider before using other skin products in conjunction with this ointment to avoid potential interactions or irritation.
Store the ointment at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
If you miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not apply extra to make up for a missed dose.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)